Shamira Shariffudin | Director Business Development |
Simba Gill | Chief Executive Officer |
Mark Bodmer | Chief Scientific Officer |
Marella Thorell | Chief Financial Officer |
Gary Nachman | BMO Capital Markets |
Gospel Enyindah-Asonye | Morgan Stanley |
Kristen Kluska | Cantor Fitzgerald |
Peyton Bohnsack | Cowen |
Good morning and welcome to the Evelo Biosciences Conference Call to discuss its Fourth Quarter and Full Year 2022 Financial Results and Business Update. [Operator Instructions] Please be advised this call is being recorded at the company's request.
At this time, I'd like to turn the call over to Shamira Shariffudin of Evelo. Please proceed.
Thank you.